We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.47%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.2B
AUM Growth
-$2.64B
(-3.2%)
Cap. Flow
-$1.24B
Cap. Flow
% of AUM
-1.54%
Top 10 Holdings %
Top 10 Hldgs %
15.46%
Holding
1,891
New
54
Increased
680
Reduced
1,031
Closed
114
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 2 |
JPMorgan Chase
JPM
|
+$525M |
| 3 |
JD.com
JD
|
+$297M |
| 4 |
Itaú Unibanco
ITUB
|
+$222M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$955M |
| 2 |
Citigroup
C
|
+$523M |
| 3 |
Nektar Therapeutics
NKTR
|
+$334M |
| 4 |
SLB Ltd
SLB
|
+$292M |
| 5 |
Alibaba
BABA
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.67% |
| 2 | Consumer Discretionary | 14.85% |
| 3 | Healthcare | 13.25% |
| 4 | Technology | 13.05% |
| 5 | Energy | 11.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Integra LifeSciences
IART
$1.57B
| $25.6M | 0.03% |
461,994
+34,167
| +8% | +$1.79M |
|
502
Huntington Ingalls Industries
HII
$11.3B
| $25.5M | 0.03% |
99,112
-6,197
| -6% | -$1.54M |
|
503
Caterpillar
CAT
$385B
| $25.4M | 0.03% |
172,653
-245,295
| -59% | -$38.7M |
|
504
Apollo Global Management
APO
$71.7B
| $25.4M | 0.03% |
856,938
+802,095
| +1,463% | +$27M |
|
505
Inogen
INGN
$174M
| $25.1M | 0.03% |
203,983
+16,605
| +9% | +$2.03M |
|
|
SNV
506
DELISTED
Synovus
SNV
| $25.1M | 0.03% |
501,677
+10,001
| +2% | +$504K |
|
507
PVH
PVH
$3.99B
| $25M | 0.03% |
165,108
+36,049
| +28% | +$5.26M |
|
508
Paycom
PAYC
$7.57B
| $25M | 0.03% |
232,401
-13,828
| -6% | -$1.33M |
|
|
CTXS
509
DELISTED
Citrix Systems Inc
CTXS
| $24.8M | 0.03% |
266,883
-148,950
| -36% | -$13.7M |
|
510
Equinix
EQIX
$103B
| $24.8M | 0.03% |
59,230
-2,313
| -4% | -$973K |
|
|
CIT
511
DELISTED
CIT Group Inc.
CIT
| $24.6M | 0.03% |
+478,397
| New | +$25.1M |
|
512
Ares Management
ARES
$28.8B
| $24.6M | 0.03% |
1,150,680
-74,164
| -6% | -$1.68M |
|
513
TE Connectivity
TEL
$61.6B
| $24.6M | 0.03% |
246,406
-163,792
| -40% | -$16.6M |
|
514
CMS Energy
CMS
$23.2B
| $24.6M | 0.03% |
542,871
-3,208
| -0.6% | -$141K |
|
515
Zurn Elkay Water Solutions
ZWS
$8.2B
| $24.6M | 0.03% |
1,717,147
+10,220
| +0.6% | +$140K |
|
|
CYS
516
DELISTED
CYS Investments Inc.
CYS
| $24.5M | 0.03% |
3,646,342
+26,349
| +0.7% | +$181K |
|
517
Tapestry
TPR
$30.3B
| $24.4M | 0.03% |
464,550
-418,569
| -47% | -$20.7M |
|
518
Novartis
NVS
$303B
| $24.4M | 0.03% |
336,943
-2,243
| -0.7% | -$171K |
|
519
BCE
BCE
$20.3B
| $24.1M | 0.03% |
560,075
-221,370
| -28% | -$9.95M |
|
|
SCG
520
DELISTED
Scana
SCG
| $24M | 0.03% |
640,101
+21,505
| +3% | +$862K |
|
521
AES
AES
$10.6B
| $24M | 0.03% |
2,109,618
-2,706
| -0.1% | -$29.4K |
|
522
CoStar Group
CSGP
$12.7B
| $23.9M | 0.03% |
659,070
+64,760
| +11% | +$2.23M |
|
523
The Greenbrier Companies
GBX
$1.59B
| $23.8M | 0.03% |
474,466
+4,368
| +0.9% | +$222K |
|
|
AMRN
524
Amarin Corp
AMRN
$290M
| $23.8M | 0.03% |
394,597
-269
| -0.1% | -$20K |
|
525
Azenta
AZTA
$1.32B
| $23.5M | 0.03% |
866,416
+2,599
| +0.3% | +$70.7K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2018 Portfolio in Review
As of Q1 2018, OppenheimerFunds held 1,891 positions worth $80.2B, down 3.2% from $82.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
OppenheimerFunds's Q1 2018 filing shows 54 new, 680 increased, 1,031 reduced and 114 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M. The largest sale was Alphabet (Google) Class C, an estimated $955M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- OppenheimerFunds's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M.
- OppenheimerFunds added most to Alphabet (Google) Class A in Q1 2018, an estimated $639M increase.
- OppenheimerFunds's biggest Q1 2018 reduction was Alphabet (Google) Class C, cutting an estimated $955M.
- OppenheimerFunds fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $77.3M.
- OppenheimerFunds's ten largest holdings make up 15% of its $80.2B portfolio in Q1 2018.
- OppenheimerFunds opened 54 new positions and closed 114 in Q1 2018.
- OppenheimerFunds's portfolio value fell 3.2% quarter-over-quarter to $80.2B.
Based on OppenheimerFunds's 13F filing for Q1 2018, filed 11 May 2018.